Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate (Q44529236)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate |
scientific article published in August 2003 |
Statements
1 reference
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate (English)
1 reference
Holger Palmedo
1 reference
Agnieska Manka-Waluch
1 reference
Peter Albers
1 reference
Ingo G H Schmidt-Wolf
1 reference
Michael Reinhardt
1 reference
Samer Ezziddin
1 reference
Alexius Joe
1 reference
Roland Roedel
1 reference
Rolf Fimmers
1 reference
F F Knapp
1 reference
Stefan Guhlke
1 reference
Hans-Jurgen Biersack
1 reference
1 August 2003
1 reference
1 reference
21
1 reference
15
1 reference
2869-2875
1 reference
Identifiers
1 reference
1 reference